Medical Device Purchases In China To Require Expert Approval
This article was originally published in PharmAsia News
Executive Summary
The Ministry of Health in China revealed that due to the large upfront investment and operational costs which will increase medical fees, big medical equipment and facilities will need expert evaluation and approval before they can be purchased and operated. The ministry requires hospitals and medical organizations installing devices exceeding 5 million yuan ($696,475 )to provide the price breakdown, treatment fees, cost analysis and other details. After giving temporary approval of one to two years, the experts will further assess the safety and effectiveness of the equipment before deciding on granting full approval. The ruling will affect large medical implementations such as PET, gamma ray stereotactic radiotherapy system (Gamma Knife), medical cyclotron, and proton therapy system. (Click here for more - Chinese Language)
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.